// App-Quantinova.ai

P451 : Safety and efficacy of ferric carboxymaltose (FCM) for the treatment of iron deficiency anaemia in paediatric patients affected by inflammatory bowel disease (pIBD)

Researchers

Presenter

  • L Cococcioni

Principal Investigators

  • A Elzein

  • S Sider

  • S Chadokufa

  • R Buckingham

  • A Ocholi

  • N Shah

  • S McCartney

  • E Saliakellis

  • O Borrelli

  • F Kiparissi

Medical Centers

  • Great Ormond Street Hospital, Gastroenterology, London, UK

  • University College London Hospital, Gastroenterology, London, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Blood/haematological Diseases

  • Genetic Disorder

  • Gastroenterology (GU)

Disease

  • Inflammatory bowel disease

  • Anemia

Biomarkers

  • C reactive protein

  • Hematocrit

  • Mean corpuscular volume

Drug/Treatment

  • Ferric carboxymaltose

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved